Revision as of 12:50, 22 October 2016 view sourceKeisyz (talk | contribs)283 edits cat← Previous edit |
Latest revision as of 08:47, 30 September 2023 view source Yellow whisper (talk | contribs)18 editsmNo edit summary |
(24 intermediate revisions by 14 users not shown) |
Line 8: |
Line 8: |
|
| state1 = uncollapsed |
|
| state1 = uncollapsed |
|
| group1 = Specific ]s and/or ]s |
|
| group1 = Specific ]s and/or ]s |
|
| list1 = {{Navbox subgroup |
|
| list1 = {{Navbox|subgroup |
|
|
|
|
|
| group1 = ]s |
|
| group1 = {{abbrlink|SSRIs|Selective serotonin reuptake inhibitors}} |
|
| list1 = |
|
| list1 = |
|
* ] |
|
* ] |
Line 21: |
Line 21: |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
|
|
|
|
| group2 = ]s |
|
| group2 = {{abbrlink|SNRIs|Serotonin–norepinephrine reuptake inhibitors}} |
|
| list2 = |
|
| list2 = |
|
* ] |
|
* ] |
Line 30: |
Line 30: |
|
* ] |
|
* ] |
|
|
|
|
|
| group3 = ]s |
|
| group3 = {{abbrlink|NRIs|Norepinephrine reuptake inhibitors}} |
|
| list3 = |
|
| list3 = |
|
* ] |
|
* ] |
Line 36: |
Line 36: |
|
* ] |
|
* ] |
|
|
|
|
|
| group4 = ]s |
|
| group4 = {{abbrlink|NDRIs|Norepinephrine–dopamine reuptake inhibitors}} |
|
| list4 = |
|
| list4 = |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
Line 42: |
Line 42: |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
|
|
|
|
| group5 = ]s |
|
| group5 = {{abbrlink|NaSSAs|Noradrenergic and specific serotonergic antidepressants}} |
|
| list5 = |
|
| list5 = |
|
* ] |
|
* ] |
Line 48: |
Line 48: |
|
* ] |
|
* ] |
|
|
|
|
|
| group6 = ]s |
|
| group6 = {{abbrlink|SARIs|Serotonin antagonist and reuptake inhibitors}} |
|
| list6 = |
|
| list6 = |
|
* ] |
|
* ] |
|
* ]<sup>‡</sup> |
|
* ] |
|
* ] |
|
* ] |
|
|
|
|
|
| group7 = ]s |
|
| group7 = {{abbrlink|SMS|Serotonin modulator and stimulators}} |
|
| list7 = |
|
| list7 = |
|
* ] |
|
* ] |
Line 63: |
Line 63: |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
|
* ] |
|
* ] |
|
|
* ] |
|
* ] |
|
* ] |
|
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ] |
|
* ] |
|
* ] |
|
⚫ |
* ] |
|
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
⚫ |
* ]<sup>§</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ] |
|
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
|
* ]<sup>‡</sup> |
|
* ] |
|
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
|
|
|
|
|
}} |
|
}} |
Line 86: |
Line 82: |
|
| state2 = uncollapsed |
|
| state2 = uncollapsed |
|
| group2 = ] and ]s |
|
| group2 = ] and ]s |
|
| list2 = {{Navbox subgroup |
|
| list2 = {{Navbox|subgroup |
|
|
|
|
|
| group1 = ]s |
|
| group1 = {{abbrlink|TCAs|Tricyclic antidepressants}} |
|
| list1 = |
|
| list1 = |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>#</sup> |
|
* ]<sup>#</sup> |
|
* ] |
|
* ] |
|
⚫ |
* ] |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>#</sup> |
|
* ]<sup>#</sup> |
Line 118: |
Line 115: |
|
* ] |
|
* ] |
|
|
|
|
|
| group2 = ]s |
|
| group2 = {{abbrlink|TeCAs|Tetracyclic antidepressants}} |
|
| list2 = |
|
| list2 = |
|
|
|
⚫ |
* ] |
|
|
* ] |
|
* ] |
|
* ] |
|
* ] |
Line 134: |
Line 131: |
|
| state3 = uncollapsed |
|
| state3 = uncollapsed |
|
| group3 = ]s |
|
| group3 = ]s |
|
| list3 = {{Navbox subgroup |
|
| list3 = {{Navbox|subgroup |
|
|
|
|
|
| group1 = Non-selective |
|
| group1 = Non-selective |
Line 142: |
Line 139: |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ] |
|
* ] |
|
|
* ]<sup>#</sup> |
|
|
* ]<sup>#</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
Line 150: |
Line 149: |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
|
* ] |
|
* ] |
|
* ] |
|
|
|
|
|
* ''Reversible:'' ]<sup>‡</sup> |
|
* ''Reversible:'' ]<sup>‡</sup> |
|
|
|
|
|
|
* ''Mixed:'' ] |
⚫ |
| group2 = MAO<sub>A</sub>-selective |
|
|
|
|
|
⚫ |
| group2 = {{abbrlink|MAO<sub>A</sub>|Monoamine oxidase A}}-selective |
|
| list2 = |
|
| list2 = |
|
|
|
|
|
* ''Reversible:'' ] |
|
* ''Reversible:'' ] |
|
* ] |
|
|
* ] |
|
* ] |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
Line 166: |
Line 167: |
|
* ] |
|
* ] |
|
|
|
|
|
| group3 = MAO<sub>B</sub>-Selective |
|
| group3 = {{abbrlink|MAO<sub>B</sub>|Monoamine oxidase B}}-selective |
|
| list3 = |
|
| list3 = |
|
* ''Irreversible:'' ] |
|
* ''Irreversible:'' ] |
Line 175: |
Line 176: |
|
| group4 = ] |
|
| group4 = ] |
|
| list4 = |
|
| list4 = |
|
* ]s (], ], ], ]) |
|
* ]s (], ], ], ], ], ]) |
|
* ] |
|
* ] |
|
* ] (], ]) |
|
* ] (], ]) |
Line 183: |
Line 184: |
|
| group5 = Miscellaneous |
|
| group5 = Miscellaneous |
|
| list5 = |
|
| list5 = |
|
* ] |
|
* ] |
|
|
* ] ]s (], ]) |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
|
* ] |
|
* ] |
|
* ] |
|
|
|
|